Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection
D Vassilopoulos, A Apostolopoulou… - Annals of the …, 2010 - ard.bmj.com
Objectives The aim of this prospective study was to examine the safety of anti-tumour
necrosis factor (TNF) therapy in patients with rheumatic disease and hepatitis B virus (HBV) …
necrosis factor (TNF) therapy in patients with rheumatic disease and hepatitis B virus (HBV) …
Elastography for hepatic fibrosis severity in chronic hepatitis B or C
MV Papageorgiou, GV Papatheodoridis… - Case Reports in …, 2011 - karger.com
Aims: To assess the value of transient elastography for predicting significant fibrosis or
cirrhosis in chronic hepatitis B or C (CHB or CHC) patients. Methods: 75 patients (CHB: 45 …
cirrhosis in chronic hepatitis B or C (CHB or CHC) patients. Methods: 75 patients (CHB: 45 …
[CITATION][C] Utility of an interferon-gamma elispot assay for mycubacterium tuberculosis (MTB) infection screening in rheumatic patients treated with anti-TNF agents
D Vassilopoulos, N Stamoulis… - ANNALS OF …, 2007 - BMJ PUBLISHING GROUP BRITISH …
[CITATION][C] Toll like receptor expression in peripheral T cells and monocytes from patients with Behcet's disease
D Vassilopoulos, M Sevastou… - ANNALS OF …, 2007 - BMJ PUBLISHING GROUP BRITISH …
[CITATION][C] TOLL LIKE RECEPTOR EXPRESSION IN T CELLS AND MONOCYTES FROM PATIENTS WITH BEHCET'S DISEASE
D Vassilopoulos, M Sevastou… - CLINICAL …, 2008 - … VIA SANTA MARIA 31, 56126 PISA …
[CITATION][C] Factors associated with glucose intolerance in patients with chronic hepatitis B or chronic hepatitis C
AN Mavrogiannaki, BG Karamanos… - …, 2008 - … 233 SPRING ST, NEW YORK, NY …